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Fibrin clot properƟes are clinically-relevant (reviewed in 44, [60] [61] [62] [63] [64] [65] The remarkable biochemical and mechanical characterisƟcs of fibrin(ogen) make it an intriguing target for new therapeuƟc approaches.
Discord may reflect complex contribuƟons of γA and γ' fibrinogen to clot properƟes. [67] [68] [69] In general, ↑ γ' is associated with arterial thrombosis, ↓ γ' with venous thrombosis, although this remains inconclusive. 66 Platelet binding Clot sƟffness Clot structure Fibrinolysis Thrombin binding ("anƟthrombin I")
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